Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-12

Clinical Trial Update: Dexmedetomidine and Vasopressin in Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 trial update on dexmedetomidine and vasopressin in septic shock; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Mansoura University | Conditions: Sepsis, Septic Shock | Phase 2 | Status: UNKNOWN